The Cochrane Library: Cochrane Database of Systematic Reviews

DOI: 10.1002/14651858

Reviews/Protocols listed by Cochrane Review Group

  1. Cochrane Acute Respiratory Infections Group
  2. Cochrane Airways Group
  3. Cochrane Anaesthesia, Critical and Emergency Care Group
  4. Cochrane Back and Neck Group
  5. Cochrane Bone, Joint and Muscle Trauma Group
  6. Cochrane Breast Cancer Group
  7. Cochrane Childhood Cancer Group
  8. Cochrane Colorectal Cancer Group
  9. Cochrane Common Mental Disorders Group
  10. Cochrane Consumers and Communication Group
  11. Cochrane Cystic Fibrosis and Genetic Disorders Group
  12. Cochrane Dementia and Cognitive Improvement Group
  13. Cochrane Developmental, Psychosocial and Learning Problems Group
  14. Cochrane Drugs and Alcohol Group
  15. Cochrane Effective Practice and Organisation of Care Group
  16. Cochrane ENT Group
  17. Cochrane Epilepsy Group
  18. Cochrane Eyes and Vision Group
  19. Cochrane Fertility Regulation Group
  20. Cochrane Gynaecological, Neuro-oncology and Orphan Cancer Group
    1. About this group
    2. Reviews
      1. Adjuvant chemotherapy after concurrent chemoradiation for locally advanced cervical cancerReview
      2. Adjuvant chemotherapy for advanced endometrial cancerReview
      3. Adjuvant chemotherapy for endometrial cancer after hysterectomyReview
      4. Adjuvant chemotherapy for localised resectable soft tissue sarcoma in adultsReview
      5. Adjuvant gonadotropin-releasing hormone analogues for the prevention of chemotherapy induced premature ovarian failure in premenopausal womenReview
      6. Adjuvant platinum-based chemotherapy for early stage cervical cancerReview
      7. Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancerReview
      8. Adjuvant progestagens for endometrial cancerReview
      9. Adjuvant radiotherapy and/or chemotherapy after surgery for uterine carcinosarcomaReview
      10. Adjuvant radiotherapy for stage I endometrial cancerReview
      11. Adjuvant treatment of anaplastic oligodendrogliomas and oligoastrocytomasReview
      12. Amphotericin B lipid soluble formulations versus amphotericin B in cancer patients with neutropeniaReview
      13. Amphotericin B versus fluconazole for controlling fungal infections in neutropenic cancer patientsReview
      14. Angiogenesis inhibitors for the treatment of ovarian cancerReview
      15. Anti-pseudomonal beta-lactams for the initial, empirical, treatment of febrile neutropenia: comparison of beta-lactamsReview
      16. Antiangiogenic therapy for high-grade gliomaReview
      17. Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapyReview
      18. Antibiotics for infection prevention after excision of the cervical transformation zoneReview
      19. Anticoagulation for people with cancer and central venous cathetersReview
      20. Anticoagulation for the initial treatment of venous thromboembolism in patients with cancerReview
      21. Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancerReview
      22. Antidepressants for the treatment of depression in people with cancerReview
      23. Antifungal therapy in infants and children with proven, probable or suspected invasive fungal infectionsReview
      24. Antigen-specific active immunotherapy for ovarian cancerReview
      25. Autologous hematopoietic stem cell transplantation following high-dose chemotherapy for nonrhabdomyosarcoma soft tissue sarcomasReview
      26. Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropeniaReview
      27. Biopsy versus resection for high grade gliomaReview
      28. Biopsy versus resection for the management of low-grade gliomasReviewNew Search
      29. Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapyReview
      30. Cardioprotective interventions for cancer patients receiving anthracyclinesReview
      31. Centralisation of services for gynaecological cancerReview
      32. Chemoradiation for advanced primary vulval cancerReview
      33. Chemotherapy and/or radiotherapy in combination with surgery for ovarian carcinosarcoma Review
      34. Chemotherapy for advanced ovarian cancerReview
      35. Chemotherapy for advanced, recurrent or metastatic endometrial carcinomaReview
      36. Chemotherapy for high-grade gliomaReview
      37. Chemotherapy for malignant germ cell ovarian cancer in adult patients with early stage, advanced and recurrent diseaseReview
      38. Chemotherapy for metastatic and recurrent cervical cancerReview
      39. Chemotherapy for resistant or recurrent gestational trophoblastic neoplasiaReview
      40. Chemotherapy for thymic carcinoma and advanced thymoma in adultsReview
      41. Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancerReview
      42. Chemotherapy wafers for high grade gliomaReview
      43. Collection devices for obtaining cervical cytology samplesReview
      44. Colony-stimulating factors for chemotherapy-induced febrile neutropeniaReview
      45. Combination chemotherapy for primary treatment of high-risk gestational trophoblastic tumourReview
      46. Combined use of hyperthermia and radiation therapy for treating locally advanced cervix carcinomaReview
      47. Communication skills training for healthcare professionals working with people who have cancerReview
      48. Concomitant chemotherapy and radiation therapy for cancer of the uterine cervixReview
      49. Concomitant hydroxyurea plus radiotherapy versus radiotherapy for carcinoma of the uterine cervixReview
      50. Cytoreductive surgery plus chemotherapy versus chemotherapy alone for recurrent epithelial ovarian cancerReview
      51. Dance/movement therapy for improving psychological and physical outcomes in cancer patientsReview
      52. Different anthracycline derivates for reducing cardiotoxicity in cancer patientsReview
      53. Different dosage schedules for reducing cardiotoxicity in people with cancer receiving anthracycline chemotherapyReview
      54. Doxorubicin-based chemotherapy for the palliative treatment of adult patients with locally advanced or metastatic soft tissue sarcomaReview
      55. Early versus delayed postoperative radiotherapy for treatment of low-grade gliomasReview
      56. Effectiveness of different treatment modalities for the management of adult-onset granulosa cell tumours of the ovary (primary and recurrent)Review
      57. Effectiveness of tranexamic acid in reducing blood loss during cytoreductive surgery for advanced ovarian cancerReview
      58. Electric fans for reducing adverse health impacts in heatwavesReview
      59. Empirical antibiotics targeting Gram-positive bacteria for the treatment of febrile neutropenic patients with cancerReview
      60. Epidermal growth factor receptor blockers for the treatment of ovarian cancerReview
      61. Evaluation of follow-up strategies for patients with epithelial ovarian cancer following completion of primary treatmentReview
      62. Exenterative surgery for recurrent gynaecological malignanciesReview
      63. Exercise interventions on health-related quality of life for cancer survivorsReview
      64. Exercise interventions on health-related quality of life for people with cancer during active treatmentReview
      65. External beam radiation dose escalation for high grade gliomaReview
      66. Fertility and early pregnancy outcomes after conservative treatment for cervical intraepithelial neoplasiaReview
      67. First-line chemotherapy in low-risk gestational trophoblastic neoplasiaReview
      68. Follow-up protocols for women with cervical cancer after primary treatmentReview
      69. Follow-up strategies after treatment (large loop excision of the transformation zone (LLETZ)) for cervical intraepithelial neoplasia (CIN): Impact of human papillomavirus (HPV) testReview
      70. Ganoderma lucidum (Reishi mushroom) for cancer treatmentReview
      71. Granulocyte transfusions for preventing infections in people with neutropenia or neutrophil dysfunctionReview
      72. Granulocyte transfusions for treating infections in people with neutropenia or neutrophil dysfunctionReview
      73. Green tea (Camellia sinensis) for the prevention of cancerReview
      74. High dose rate versus low dose rate intracavity brachytherapy for locally advanced uterine cervix cancerReview
      75. Hormonal therapy in advanced or recurrent endometrial cancerReview
      76. Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesionsReviewDiagnostic
      77. Hyperbaric oxygen therapy for late radiation tissue injuryReview
      78. Hyperbaric oxygenation for tumour sensitisation to radiotherapyReview
      79. Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancerReview
      80. Image guided surgery for the resection of brain tumoursReview
      81. Immediate referral to colposcopy versus cytological surveillance for minor cervical cytological abnormalities in the absence of HPV testReview
      82. Influenza vaccines in immunosuppressed adults with cancerReview
      83. Interferon after surgery for women with advanced (Stage II-IV) epithelial ovarian cancerReview
      84. Interval debulking surgery for advanced epithelial ovarian cancerReview
      85. Interventions for encouraging sexual behaviours intended to prevent cervical cancerReview
      86. Interventions for preventing and ameliorating cognitive deficits in adults treated with cranial irradiationReview
      87. Interventions for preventing blood loss during the treatment of cervical intraepithelial neoplasiaReview
      88. Interventions for promoting habitual exercise in people living with and beyond cancerReview
      89. Interventions for psychosexual dysfunction in women treated for gynaecological malignancyReview
      90. Interventions for reducing anxiety in women undergoing colposcopyReview
      91. Interventions for the management of fatigue in adults with a primary brain tumourReview
      92. Interventions for the physical aspects of sexual dysfunction in women following pelvic radiotherapyReview
      93. Interventions for the treatment of borderline ovarian tumoursReview
      94. Interventions for the treatment of Paget's disease of the vulvaReview
      95. Interventions targeted at women to encourage the uptake of cervical screeningReview
      96. Intraoperative frozen section analysis for the diagnosis of early stage ovarian cancer in suspicious pelvic massesReviewDiagnostic
      97. Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancerReview
      98. Laetrile treatment for cancerReview
      99. Laparoscopically assisted radical vaginal hysterectomy versus radical abdominal hysterectomy for the treatment of early cervical cancerReview
      100. Laparoscopy for diagnosing resectability of disease in patients with advanced ovarian cancerReviewDiagnostic
      101. Laparoscopy versus laparotomy for FIGO stage I ovarian cancerReview
      102. Laparoscopy versus laparotomy for the management of early stage endometrial cancerReview
      103. Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancerReview
      104. Luteinising hormone releasing hormone (LHRH) agonists for the treatment of relapsed epithelial ovarian cancerReview
      105. Lymphadenectomy for the management of endometrial cancerReview
      106. Maintenance chemotherapy for ovarian cancerReview
      107. Management of drainage for malignant ascites in gynaecological cancerReview
      108. Medical and surgical interventions for the treatment of usual-type vulval intraepithelial neoplasiaReview
      109. Medical interventions for high-grade vulval intraepithelial neoplasiaReview
      110. Mistletoe therapy in oncologyReview
      111. Multidimensional rehabilitation programmes for adult cancer survivorsReview
      112. Music interventions for improving psychological and physical outcomes in cancer patientsReview
      113. Neoadjuvant chemotherapy for locally advanced cervix cancerReview
      114. Neoadjuvant chemotherapy plus surgery versus surgery for cervical cancerReview
      115. Non-pharmacological interventions for cognitive impairment due to systemic cancer treatmentReview
      116. Non-steroidal anti-inflammatory agents to induce regression and prevent the progression of cervical intraepithelial neoplasiaReview
      117. Non-surgical interventions for late radiation cystitis in patients who have received radical radiotherapy to the pelvisReview
      118. Non-surgical interventions for late rectal problems (proctopathy) of radiotherapy in people who have received radiotherapy to the pelvisReview
      119. Nutritional interventions for reducing gastrointestinal toxicity in adults undergoing radical pelvic radiotherapyReview
      120. Nystatin prophylaxis and treatment in severely immunodepressed patientsReview
      121. Optimal primary surgical treatment for advanced epithelial ovarian cancerReview
      122. Oral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulationReview
      123. Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patientsReview
      124. Pain relief for women with cervical intraepithelial neoplasia undergoing colposcopy treatmentReview
      125. Palliative interventions for controlling vaginal bleeding in advanced cervical cancerReview
      126. Palliative surgery versus medical management for bowel obstruction in ovarian cancerReview
      127. Parenteral anticoagulation in ambulatory patients with cancerReview
      128. Patient-reported outcome measures for follow-up after gynaecological cancer treatmentReview
      129. Pegylated liposomal doxorubicin for first-line treatment of epithelial ovarian cancerReview
      130. Pegylated liposomal doxorubicin for relapsed epithelial ovarian cancerReview
      131. Perioperative enhanced recovery programmes for gynaecological cancer patientsReview
      132. Perioperative nutrition interventions for women with ovarian cancerReview
      133. Pharmacological treatment of depression in patients with a primary brain tumourReview
      134. Poly(ADP-ribose) polymerase (PARP) inhibitors for the treatment of ovarian cancerReview
      135. Polymerase chain reaction blood tests for the diagnosis of invasive aspergillosis in immunocompromised peopleReviewDiagnostic
      136. Pre-treatment surgical para-aortic lymph node assessment in locally advanced cervical cancerReview
      137. Primary groin irradiation versus primary groin surgery for early vulvar cancerReview
      138. Primary surgery versus primary radiotherapy with or without chemotherapy for early adenocarcinoma of the uterine cervixReview
      139. Prophylactic antibiotics for preventing Gram positive infections associated with long-term central venous catheters in oncology patientsReview
      140. Prophylactic chemotherapy for hydatidiform mole to prevent gestational trophoblastic neoplasiaReview
      141. Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patientsReview
      142. Psychosocial interventions to improve quality of life and emotional wellbeing for recently diagnosed cancer patientsReview
      143. Radiotherapy and chemoradiation after surgery for early cervical cancerReview
      144. Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: individual patient data meta-analysisReview
      145. Retinoids for preventing the progression of cervical intra-epithelial neoplasiaReview
      146. Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy for the prevention of lymphocyst formation in patients with gynaecological malignanciesReview
      147. Risk of endometrial cancer in women treated with ovary-stimulating drugs for subfertilityReview
      148. Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertilityReview
      149. Robot-assisted surgery in gynaecologyReview
      150. Robotic assisted surgery for gynaecological cancerReview
      151. Robotic surgery for benign gynaecological diseaseReviewWithdrawn
      152. Routine versus selective antifungal administration for control of fungal infections in patients with cancerReview
      153. Selenium for preventing cancerReview
      154. Sentinel node assessment for diagnosis of groin lymph node involvement in vulval cancerReviewDiagnostic
      155. Short versus long duration infusions of paclitaxel for any advanced adenocarcinomaReview
      156. Surgery for cervical intraepithelial neoplasiaReview
      157. Surgery or radiosurgery plus whole brain radiotherapy versus surgery or radiosurgery alone for brain metastasesReview
      158. Surgical cytoreduction for recurrent epithelial ovarian cancerReview
      159. Surgical interventions for early squamous cell carcinoma of the vulvaReview
      160. Surgical interventions for high-grade vulval intraepithelial neoplasiaReview
      161. Surgical resection and whole brain radiation therapy versus whole brain radiation therapy alone for single brain metastasesReview
      162. Surgical treatment of stage IA2 cervical cancerReview
      163. Tamoxifen for relapse of ovarian cancerReview
      164. Temozolomide for high grade gliomaReview
      165. Thalidomide for managing cancer cachexiaReview
      166. Thymic peptides for treatment of cancer patientsReview
      167. Topotecan for ovarian cancerReview
      168. Ultra-radical (extensive) surgery versus standard surgery for the primary cytoreduction of advanced epithelial ovarian cancerReview
      169. Vaginal dilator therapy for women receiving pelvic radiotherapyReview
      170. Voriconazole versus amphotericin B or fluconazole in cancer patients with neutropeniaReview
      171. Whole brain radiation therapy (WBRT) alone versus WBRT and radiosurgery for the treatment of brain metastasesReview
      172. Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastasesReview
    3. Protocols
      1. (1[RIGHTWARDS ARROW]3)β-D-glucan testing for the detection of invasive fungal infections in immunocompromised patientsProtocolDiagnostic
      2. Adjuvant radiotherapy after surgery for vulval cancerProtocol
      3. Adjuvant treatment after hysterectomy for uterine leiomyosarcomaProtocol
      4. Awake language mapping for cerebral glioma surgeryProtocolWithdrawn
      5. Cytology versus HPV testing for cervical cancer screening in the general populationProtocolDiagnostic
      6. Debulking hysterectomy followed by chemoradiotherapy versus chemoradiotherapy for FIGO stage IB2/II cervical cancerProtocol
      7. Dietary interventions for adult cancer survivorsProtocol
      8. Early discontinuation of antibiotics for febrile neutropenia versus continuation until neutropenia resolutionProtocol
      9. Exercise interventions for people undergoing multimodal cancer treatment that includes surgeryProtocol
      10. Extended-field irradiation for locally advanced cervical cancerProtocol
      11. First- and second-line systemic treatments for metastatic and locally advanced soft tissue sarcomas in adultsProtocol
      12. Follow-up strategies for women with endometrial cancer after primary treatmentProtocol
      13. Gemcitabine for platinum-resistant or recurrent ovarian cancerProtocol
      14. Ginseng for improving the quality of life in people with cancerProtocol
      15. Hormone replacement therapy after surgery for epithelial ovarian cancerProtocol
      16. Hormone replacement therapy for women previously treated for endometrial cancerProtocol
      17. Immune checkpoint blockade for gliomaProtocol
      18. Impact of epithelial ovarian cancer screening on patient-relevant outcomes in average-risk postmenopausal womenProtocol
      19. Interventions for the treatment of brain radionecrosis after radiotherapy or radiosurgeryProtocol
      20. Interventions for weight reduction in obesity to improve survival in women with endometrial cancerProtocol
      21. Interventions to help support caregivers of people with a brain or spinal cord tumourProtocol
      22. Interventions to reduce acute and late adverse gastrointestinal effects of pelvic radiotherapyProtocol
      23. Intra-arterial chemotherapy for high-grade gliomasProtocolWithdrawn
      24. Intralesional treatment versus wide resection for central chondrosarcoma grade I in the long bonesProtocol
      25. Low cost versus other screening tests to detect cervical cancer or precancer in developing countriesProtocolDiagnostic
      26. Lymph node dissection (lymphadenectomy) for presumed early stage epithelial ovarian cancerProtocol
      27. Magnetic resonance perfusion for differentiating low grade from high grade gliomas at first presentationProtocolDiagnostic
      28. Maintenance bioimmunotherapy for epithelial ovarian cancerProtocolWithdrawn
      29. Melatonin in cancer treatmentProtocol
      30. Moxibustion for alleviating side effects of chemotherapy or radiotherapy in cancer patientsProtocol
      31. Non-pharmacological interventions for the treatment of sleep-wake disturbances in patients with cancerProtocol
      32. Outpatient treatment for patients with cancer who develop a low-risk febrile neutropenic eventProtocol
      33. Pentoxifylline and vitamin E alone or in combination for preventing and treating side effects of radiation therapy and concomitant chemoradiotherapyProtocol
      34. Pharmacological interventions for the prevention of insufficiency fractures and avascular necrosis associated with pelvic radiotherapy in adultsProtocol
      35. PI3K/AKT/mTOR inhibitors for advanced or recurrent endometrial cancerProtocol
      36. Positron emission tomography (PET) and magnetic resonance imaging (MRI) for assessing tumour resectability in advanced epithelial ovarian, fallopian tube and/or primary peritoneal cancerProtocolDiagnostic
      37. Probiotics for the prevention or treatment of chemotherapy or radiotherapy related diarrhoea in cancer patientsProtocol
      38. Procarbazine, lomustine and vincristine for recurrent high-grade gliomaProtocol
      39. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursorsProtocol
      40. Psychological interventions for cancer survivors and cancer patients in the palliative phaseProtocol
      41. Risk-reducing bilateral salpingo-oophorectomy in women with BRCA1 or BRCA2 mutationsProtocol
      42. Sentinel node biopsy for diagnosis of pelvic lymph node involvement in early stage cervical cancerProtocolDiagnostic
      43. Simple versus radical hysterectomy with pelvic lymphadenectomy for women with stage IA2-IB1 cervical cancerProtocol
      44. Surgery plus adjuvant radiotherapy versus surgery alone for stage II endometrial cancerProtocol
      45. Surgery versus radiosurgery for people with single or solitary brain metastasesProtocol
      46. Symptoms, ultrasound imaging and biochemical markers alone or in combination for the diagnosis of ovarian cancer in women with symptoms suspicious of ovarian cancerProtocolDiagnostic
      47. Systematic screening and assessment of psychosocial well-being and care needs of people with cancerProtocol
      48. Taxane monotherapy for the treatment of platinum pre-treated epithelial ovarian cancerProtocol
      49. Taxane platinum combination chemotherapy versus single agent platinum for the first line treatment of epithelial ovarian cancerProtocolWithdrawn
      50. Telephone interventions for symptom management in adults with cancerProtocol
      51. Type II or type III radical hysterectomy compared to chemoradiotherapy as a primary treatment for stage IB2 cervical cancerProtocol
      52. Weekly versus tri-weekly paclitaxel with carboplatin for first-line treatment in women with ovarian cancerProtocol
  21. Cochrane Gynaecology and Fertility Group
  22. Cochrane Haematological Malignancies Group
  23. Cochrane Heart Group
  24. Cochrane Hepato-Biliary Group
  25. Cochrane HIV/AIDS Group
  26. Cochrane Hypertension Group
  27. Cochrane IBD Group
  28. Cochrane Incontinence Group
  29. Cochrane Infectious Diseases Group
  30. Cochrane Injuries Group
  31. Cochrane Kidney and Transplant Group
  32. Cochrane Lung Cancer Group
  33. Cochrane Metabolic and Endocrine Disorders Group
  34. Cochrane Methodology Review Group
  35. Cochrane Movement Disorders Group
  36. Cochrane Multiple Sclerosis and Rare Diseases of the CNS Group
  37. Cochrane Musculoskeletal Group
  38. Cochrane Neonatal Group
  39. Cochrane Neuromuscular Group
  40. Cochrane Oral Health Group
  41. Cochrane Pain, Palliative and Supportive Care Group
  42. Cochrane Pregnancy and Childbirth Group
  43. Cochrane Public Health Group
  44. Cochrane Schizophrenia Group
  45. Cochrane Skin Group
  46. Cochrane STI Group
  47. Cochrane Stroke Group
  48. Cochrane Tobacco Addiction Group
  49. Cochrane Upper GI and Pancreatic Diseases Group
  50. Cochrane Urology Group
  51. Cochrane Vascular Group
  52. Cochrane Work Group
  53. Cochrane Wounds Group